R-BAC regimen good for older mantle cell lymphoma patients

Submitted by Ross Bonander Fri 12/16/2011

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

At the recent ASH meeting in San Diego, researchers from Italy presented data supporting the use of a new chemotherapy regimen in patients with previously untreated mantle cell lymphoma (MCL), or in patients with relapsed or refractory mantle cell lymphoma who had previously received one line of immunochemotherapy.

The regimen, R-BAC (rituximab, bendamustine, and cytarabine) was given to MCL patients aged 65 or older over 4-6 28 day cycles. A total of 37 patients were enrolled n the phase II study, the overwhelming majority of them with advanced stage (III or IV) disease. The median age of patients was 71.

Overall response rate (ORR) was 88%, and complete response rate (CRR) was 74%. CRR was higher among the treatment naïve patients. At a median 13 month follow-up, the 1 year progression free survival (PFS) rate was 87% in the treatment naïve patients and 62 in the other arm of the trial.

Researchers concluded that the R-BAC regimen not only has potential in treating patients over the age of 65 with mantle cell lymphoma, it is also well-tolerated.

EMPR.com

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.